findmyKOL
Clinical trialNCT00293657CompletedPhase 2Interventional

Study of Lornoxicam or Placebo for Acute Treatment of the Headache of Migraine.

SponsorPOZENEnrollment150Headache (Migraine)
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

To determine whether a single dose of intravenous lornoxicam is superior to intravenous placebo for the acute treatment of moderate or severe headache associated with a single migraine attack in patients with a history of migraine. Two-thirds of patients in this study will receive a single dose of intravenous lornoxicam (8mg or 16 mg) and one-third of patients will receive a single dose of an intravenous placebo.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

23 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Alabama Clinical Therapeutics

    Birmingham, Alabama, United States

  • University of South Alabama Neurology

    Mobile, Alabama, United States

  • Little Rock Family Practice Clinic

    Little Rock, Arkansas, United States

  • C. Phillip O'Carroll, Md, Inc.

    Newport Beach, California, United States

  • California Medical Clinic for Headache

    Santa Monica, California, United States

  • New England Center for Headache

    Stamford, Connecticut, United States

  • Meridien Research

    St. Petersburg, Florida, United States

  • Premiere Research Institute

    West Palm Beach, Florida, United States

  • Diamond Headache Clinic

    Chicago, Illinois, United States

  • Ne Medical Research Associates, Inc.

    North Dartmouth, Massachusetts, United States

  • Michigan Head Pain and Neurological Institute

    Ann Arbor, Michigan, United States

  • Clinical Research Institute

    Plymouth, Minnesota, United States

  • Headache Care Center

    Springfield, Missouri, United States

  • Mercy Health Reserach / Ryan Headache Center

    St Louis, Missouri, United States

  • University Headache Center

    Chapel Hill, North Carolina, United States

  • Headache Wellness Center

    Greensboro, North Carolina, United States

  • North Carolina Clinical Research

    Raleigh, North Carolina, United States

  • Jefferson Headache Center

    Philadelphia, Pennsylvania, United States

  • Clinical Research Associates, Inc.

    Nashville, Tennessee, United States

  • Houston Headache Clinic

    Houston, Texas, United States

  • Jean Brown Research

    Salt Lake City, Utah, United States

  • the Innovative Clinical Research Center

    Alexandria, Virginia, United States

  • Swedish Pain Center

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

LornoxicamPlacebo
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Dec 2005
Primary completion
30 Apr 2006
Completion
30 Apr 2006
Last update posted
3 Dec 2012
Registered enrollment
150
Registry id
NCT00293657

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.